Gennex Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 930938, "name": "Gennex Lab.", "stock_name": "Gennex Lab.", "full_name": "Gennex Laboratories Ltd", "name_url": "stocks-analysis/gennex-lab", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "10.27", "chg": -0.16, "chgp": "-1.53%", "dir": -1, "prev_price": "10.43", "mcapval": "250.00 Cr", "mcap": "Micro Cap", "scripcode": 531739, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE509C01026", "curr_date": "Sep 18, 03:30 PM", "curr_time": "00:05 AM", "last_traded_at": "Sep 18, 03:30 PM IST", "bse_nse_vol": "3.12 lacs", "exc_status": "Active", "traded_date": "Sep 18, 2026", "traded_date_str": "2026 09 18", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gennex-lab-930938-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Gennex Laboratories Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4186037", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GennexLaborator_mojoScore_4186037.png", "date": "2026-09-08 09:02:34", "description": "Gennex Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 7 September 2026. This change reflects a combination of deteriorating technical indicators, flat recent financial performance, and concerns over promoter share pledging, despite attractive valuation metrics and long-term market-beating returns." }, { "title": "Gennex Laboratories Declines 6.12% Amid Valuation Reset and Technical Upgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-declines-612-amid-valuation-reset-and-technical-upgrade-4183581", "imagepath": "", "date": "2026-09-05 14:06:59", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>31 Aug:</strong> Stock opens at ₹12.62, down 2.25% amid broader market weakness</p>\n <p><strong>1 Sep:</strong> Mojo grade upgraded to Hold on improved technicals and valuation</p>\n <p><strong>2-3 Sep:</strong> Continued price decline with subdued volumes</p>\n <p><strong>4 Sep:</strong> Price rebounds 2.71% to close at ₹12.12, Sensex gains 0.19%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹12.91</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div cla..." }, { "title": "Gennex Laboratories Ltd Upgraded to Hold on Improved Technicals and Valuation", "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-upgraded-to-hold-on-improved-technicals-and-valuation-4177174", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GennexLaborator_mojoScore_4177174.png", "date": "2026-09-01 08:43:36", "description": "Gennex Laboratories Ltd has seen its investment rating upgraded from Sell to Hold as of 31 August 2026, reflecting a notable improvement in its technical outlook and valuation metrics. Despite a flat financial performance in the recent quarter, the company’s stock has demonstrated resilience and outperformance relative to the broader market, prompting a reassessment of its investment appeal." }, { "title": "Gennex Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4176645", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GennexLaborator_valuationdot_4176645.png", "date": "2026-09-01 08:00:57", "description": "Gennex Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive grade, signalling a potential opportunity for investors in the Pharmaceuticals & Biotechnology sector. This re-rating comes amid a backdrop of mixed sector valuations and a micro-cap status that warrants close attention." }, { "title": "Gennex Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-4173216", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GennexLaborator_mojoScore_4173216.png", "date": "2026-08-28 10:11:16", "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "Gennex Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4166385", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GennexLaborator_valuationdot_4166385.png", "date": "2026-08-24 08:00:55", "description": "Gennex Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a more compelling price proposition for investors. Despite a recent downgrade in its overall Mojo Grade to Sell, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a valuation that is increasingly appealing relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector." }, { "title": "Gennex Laboratories Downgraded to Sell Amid Mixed Financials and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-downgraded-to-sell-amid-mixed-financials-and-technical-signals-4157286", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GennexLaborator_mojoScore_4157286.png", "date": "2026-08-17 08:25:16", "description": "Gennex Laboratories Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a complex interplay of financial stagnation, valuation appeal, and shifting technical indicators. Despite a strong long-term operating profit growth and attractive valuation metrics, recent quarterly results and technical trends have prompted a reassessment of the stock’s outlook." }, { "title": "Gennex Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-4147080", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GennexLaborator_mojoScore_4147080.png", "date": "2026-08-11 10:11:23", "description": "Gennex Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 11 August 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Gennex Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-4130011", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GennexLaborator_mojoScore_4130011.png", "date": "2026-07-31 10:11:38", "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with the latest insights into its performance and outlook." } ], "total": 194, "sid": "930938", "stock_news_url": "https://www.marketsmojo.com/news/gennex-laboratories-930938" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "09-Sep-2026", "details": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication of AGM Notice and eVoting related instructions advertisement published in Business Standard and Saksham (Telugu - Local) on September 09 2026 for the 41st Annual General Meeting of the Company to be held on September 30 2026.", "source": "BSE" }, { "caption": "Reg. 34 (1) Annual Report.", "datetime": "08-Sep-2026", "details": "With reference to the subject matter As per the Regulation 34 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we hereby submits 41st Annual Report of Gennex Laboratories Limited for the Financial Year ended March 31 2026 inter alia Notice of the Annual General Meeting to be held on Wednesday September 30 2026 Directors Report Independent Audit Report of Statutory Auditor Financial Statements (Standalone and Consolidated) being Balance Sheet Statement of Profit and Loss account & Cash Flow Statement along with the Notes thereto for the Financial Year ended March 31 2026 have been sent electronically to the members who have registered their email ID as per the SEBI guideline. The aforesaid documents are available on the Company website i.e. www.gennexlab.com and are also available for inspection at the Registered Office of the Company during office hours.", "source": "BSE" }, { "caption": "Approval Of Additional Products From Drugs Control Administration Government Of Andhra Pradesh For Our Subsidiary Company Deccan Remedies Limited", "datetime": "08-Sep-2026", "details": "We are pleased to inform that our subsidiary company M/s Deccan Remedies Limited has received approval from the Drugs Control Administration Government of Andhra Pradesh granting License for Manufacturing of additional Products under form 25 and Test License for the purpose of examination test or analysis under Form 29.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Gennex Laboratories Ltd has announced <strong>1:10</strong> stock split, ex-date: 14 Dec 09", "dt": "2009-12-14", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Gennex Laboratories Ltd has announced <strong>1:2</strong> rights issue, ex-date: 21 Jul 22", "dt": "2022-07-21", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

31 Aug: Stock opens at ₹12.62, down 2.25% amid broader market weakness

1 Sep: Mojo grade upgraded to Hold on improved technicals and valuation

2-3 Sep: Continued price decline with subdued volumes

4 Sep: Price rebounds 2.71% to close at ₹12.12, Sensex gains 0.19%

Week Open

₹12.91

Week Close

Read full news article

Gennex Laboratories Ltd Upgraded to Hold on Improved Technicals and Valuation

2026-09-01 08:43:36

Gennex Laboratories Ltd has seen its investment rating upgraded from Sell to Hold as of 31 August 2026, reflecting a notable improvement in its technical outlook and valuation metrics. Despite a flat financial performance in the recent quarter, the company’s stock has demonstrated resilience and outperformance relative to the broader market, prompting a reassessment of its investment appeal.

Read full news article

Gennex Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-09-01 08:00:57

Gennex Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive grade, signalling a potential opportunity for investors in the Pharmaceuticals & Biotechnology sector. This re-rating comes amid a backdrop of mixed sector valuations and a micro-cap status that warrants close attention.

Read full news article

Gennex Laboratories Ltd is Rated Sell

2026-08-28 10:11:16

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Gennex Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-08-24 08:00:55

Gennex Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a more compelling price proposition for investors. Despite a recent downgrade in its overall Mojo Grade to Sell, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a valuation that is increasingly appealing relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector.

Read full news article

Gennex Laboratories Downgraded to Sell Amid Mixed Financials and Technical Signals

2026-08-17 08:25:16

Gennex Laboratories Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a complex interplay of financial stagnation, valuation appeal, and shifting technical indicators. Despite a strong long-term operating profit growth and attractive valuation metrics, recent quarterly results and technical trends have prompted a reassessment of the stock’s outlook.

Read full news article

Gennex Laboratories Ltd is Rated Sell

2026-08-11 10:11:23

Gennex Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 11 August 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Gennex Laboratories Ltd is Rated Sell

2026-07-31 10:11:38

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article